Pharmaceutical Technology18h
FDA approves Azurity Pharmaceuticals’ Danziten for CML treatment
The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...
Pharmaceutical Technology19h
Bavarian Nordic shares sink by 12% after mpox sales slump in Q3
The Danish infectious disease specialist has $340m (DKK 2.4m) lined up through orders for its MVA-BN vaccine known under the ...
Pharmaceutical Technology17h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Pharmaceutical Technology17h
AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Pharmaceutical Technology21h
Patient experience in the spotlight at Clinical Trials in Oncology Europe 2024
The two-day Oncology event will see industry experts from across the clinical trial space holding talks on subjects from AI ...
Pharmaceutical Technology9h
Merative MarketScan
The FDA has released final draft recommendations for using real-world data and evidence in drug development.